Caitong Fund Management Co., Ltd., GF Securities Co., Ltd. (SZSE:000776), Guotai Asset Management Company Limited, Taikang Asset Management Co., Ltd., Shanghai Hongshang Asset Management Center (Limited Partnership) and Guotai Haitong Securities Co., Ltd. (SHSE:601211) acquired 2% stake in Shanghai Sanyou Medical Co., Ltd (SHSE:688085) from QM5 Limited for CNY 120 million on September 26, 2025. A cash consideration of CNY 120.78 million will be paid by Caitong Fund Management Co., Ltd., GF Securities Co., Ltd., Guotai Asset Management Company Limited, Taikang Asset Management Co., Ltd., Shanghai Hongshang Asset Management Center (Limited Partnership) and Guotai Haitong Securities Co., Ltd. As part of consideration, CNY 120.78 million is paid towards common equity of Shanghai Sanyou Medical Co., Ltd.
Before completion, QM5 Limited owned 14.74% stake in Shanghai Sanyou Medical Co., Ltd. After completion, QM5 Limited now owns 12.74% stake in Shanghai Sanyou Medical Co., Ltd.
Caitong Fund Management Co., Ltd., GF Securities Co., Ltd. (SZSE:000776), Guotai Asset Management Company Limited, Taikang Asset Management Co., Ltd., Shanghai Hongshang Asset Management Center (Limited Partnership) and Guotai Haitong Securities Co., Ltd. (SHSE:601211) completed the acquisition of 2% stake in Shanghai Sanyou Medical Co., Ltd (SHSE:688085) from QM5 Limited on September 26, 2025.
Shanghai Sanyou Medical Co Ltd is a China-based company mainly engaged in medical equipment business. The Company's main business is the research, development, manufacturing and sales of medical orthopedic implant consumables. Its main products include spinal implant consumable products and trauma implant consumable products. In addition, the Company also develops and produces supporting surgical tools. The Company distributes its products within domestic market and to overseas markets.
